Acid-reducing medicine for ICU patients after surgery
Treatments studied
Part of Digestive system clinical trials.
This trial tests a medicine called esomeprazole, given through an IV, to see if it safely prevents stomach bleeding in patients who are in the ICU after surgery. If you qualify, you might get this medicine to help protect your stomach while you recover.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old and are in the ICU after surgery.
- Your surgery was not on your stomach or food pipe (esophagus).
- You are expected to stay in the ICU for at least 3 days.
- You do not have a feeding tube or need liquid food through a tube.
- You are not already taking certain acid-reducing medicines or pain relievers (like ibuprofen) in the last 2 days.
- You do not have severe liver disease, a bleeding disorder, or have had an organ transplant requiring anti-rejection medicines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests vonaprazan (two doses) against esomeprazole to see which better heals moderate-to-severe reflux esophagitis (a damaged esophagus from acid reflux) in 8 weeks. You may qualify if you have had heartburn or regurgitation for at least a month and your doctor found grade B, C, or D damage on an endoscopy.
This study compares two medications—vonoprazan and esomeprazole—to see which one heals acid reflux-related damage in the esophagus better after POEM surgery for achalasia. If you have had POEM and now have heartburn and moderate to severe esophagitis, this trial may help find the best treatment for you.
This trial compares two medicines that reduce stomach acid to help heal ulcers that form after a procedure called ESD, which removes abnormal stomach tissue. The goal is to see if one medicine works better and has fewer side effects.
This trial compares an IV “acid-suppressing” medicine (PPI infusion) with acid pills (oral PPIs) after doctors treat a bleeding peptic ulcer endoscopically. It may help prevent re-bleeding by keeping stomach acid low while the ulcer heals.
This study tests whether adding sucralfate (a stomach-lining protectant) to the standard acid-reducer esomeprazole helps heal ulcers that form after a procedure called ESD for early stomach cancer. It helps find which combination works better for recovery.
This trial tests whether a common acid-reducing medicine (a proton pump inhibitor) helps people with cirrhosis who are having bleeding from enlarged veins in the esophagus. The goal is to see if it improves outcomes after emergency treatment.
Hear when a new Stress Ulcers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.